4//SEC Filing
Reynolds Cameron John 4
Accession 0001078782-20-000367
CIK 0000093314other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:27 PM ET
Size
6.7 KB
Accession
0001078782-20-000367
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Reynolds Cameron John
DirectorPRESIDENT AND CEO
Transactions
- Purchase
Common Stock
2020-05-22$2.75/sh+4,000$11,000→ 1,126,273 total
Holdings
- 34,076(indirect: By Spouse)
Common Stock
- 1,007,718(indirect: Concord International, Inc.)
Common Stock
Footnotes (2)
- [F1]The shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on May 22, 2020. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriter.
- [F2]The shares of Common Stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc.
Documents
Issuer
VOLITIONRX LTD
CIK 0000093314
Entity typeother
Related Parties
1- filerCIK 0001340610
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:27 PM ET
- Size
- 6.7 KB